Author(s):
Prakash Nathaniel Kumar Sarella, Vinny Therissa Mangam
Email(s):
sarellaprakash@acop.edu.in
DOI:
10.52711/2231-5713.2024.00044 
Address:
Prakash Nathaniel Kumar Sarella*, Vinny Therissa Mangam
Department of Pharmacy, Aditya College of Pharmacy, ADB Road, Surampalem, Kakinada - 533437, Andhra Pradesh, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 3,
Year - 2024
ABSTRACT:
Nutraceuticals, encompassing vitamins, minerals, and dietary supplements, play a pivotal role in promoting health and wellness. However, their therapeutic efficacy is often hindered by poor bioavailability. Bilosomes, a burgeoning lipid-based nanocarrier, have emerged as a promising solution to overcome this challenge. This comprehensive review explores the potential of bilosomes as carriers for enhancing the bioavailability of nutraceuticals, shedding light on their formulation, characterization, mechanisms of action, safety considerations, and future prospects. The review begins by delineating the significance of nutraceuticals in promoting well-being and discusses the obstacles associated with their delivery. It subsequently introduces bilosomes, lipid vesicles equipped with bile salts, and elucidates their advantages over traditional delivery systems. A comparative analysis with other lipid-based carriers underscores the unique attributes that make bilosomes an attractive choice for nutraceutical delivery. A deeper dive into bilosome formulation and characterization provides insights into lipid composition, encapsulation techniques, and physicochemical characterization methods. Factors influencing bilosome stability and bioavailability, including size, surface charge, and interactions with physiological barriers, are comprehensively reviewed. Safety and toxicological considerations related to bilosome-based nutraceutical delivery are meticulously examined, drawing from preclinical and clinical studies. Regulatory aspects pertinent to bilosome incorporation in nutraceutical products are outlined. Future perspectives delve into emerging trends, formulation challenges, and the potential for personalized nutrition with bilosomes. In conclusion, this review underscores the transformative potential of bilosomes in enhancing nutraceutical bioavailability, opening new vistas in the field of personalized nutrition and health promotion.
Cite this article:
Prakash Nathaniel Kumar Sarella, Vinny Therissa Mangam. Enhancing Nutraceutical Bioavailability with Bilosomes: A Comprehensive Review. Asian Journal of Pharmacy and Technology. 2024; 14(3):271-0. doi: 10.52711/2231-5713.2024.00044
Cite(Electronic):
Prakash Nathaniel Kumar Sarella, Vinny Therissa Mangam. Enhancing Nutraceutical Bioavailability with Bilosomes: A Comprehensive Review. Asian Journal of Pharmacy and Technology. 2024; 14(3):271-0. doi: 10.52711/2231-5713.2024.00044 Available on: https://ajptonline.com/AbstractView.aspx?PID=2024-14-3-13
REFERENCES:
1. Alenzi AM, Albalawi SA, Alghamdi SG, Albalawi RF, Albalawi HS, Qushawy M. Review on different vesicular drug delivery systems (VDDSs) and their applications. Recent Pat Nanotechnol. 2023; 17(1): 18-32.
2. Kecman S, Škrbić R, Badnjevic Cengic A, et al. Potentials of human bile acids and their salts in pharmaceutical nano delivery and formulations adjuvants. Technol Health Care. 2020; 28(3): 325-335.
3. Myschik J, Rades T, Hook S. Advances in lipid-based subunit vaccine formulations. Curr Immunol Rev. 2009; 5(1): 42-48.
4. Saifi Z, Rizwanullah M, Mir SR, Amin S. Bilosomes nanocarriers for improved oral bioavailability of acyclovir: A complete characterization through in vitro, ex-vivo and in vivo assessment. J Drug Deliv Sci Technol. 2020; 57: 101634.
5. Wanjari AS, Desai PR. Standardization of Some Herbal and Neutraceuticals Product. Res J Pharmacogn Phytochem. 2015; 7(3): 133. doi:10.5958/0975-4385.2015.00023.0
6. Wilkhu JS, McNeil SE, Anderson DE, Perrie Y. Characterization and optimization of bilosomes for oral vaccine delivery. J Drug Target. 2013; 21(3): 291-299. doi:10.3109/1061186X.2012.747528
7. Aditya NP, Espinosa YG, Norton IT. Encapsulation systems for the delivery of hydrophilic nutraceuticals: Food application. Biotechnol Adv. 2017; 35(4): 450-457.
8. Hegazy H, Amin MM, Fayad W, Zakaria MY. TPGS surface modified bilosomes as boosting cytotoxic oral delivery systems of curcumin against doxorubicin resistant MCF-7 breast cancer cells. Int J Pharm. 2022; 619: 121717.
9. Liu C, Guo Y, Cheng Y, Qian H. Bilosomes: A controlled delivery system for the sustained release of torularhodin during digestion in the small intestine both in vitro and in vivo. Colloids Surf Physicochem Eng Asp. 2022; 654: 130055.
10. Sreeramya G, Nalini CN, Ramalakshmi N, Sahini K, Lakshmi SA. A new Era in Medicine – Neutraceuticals. Res J Pharm Technol. 2018; 11(8): 3572. doi:10.5958/0974-360X.2018.00657.1
11. Nayak A, Espinosa YG, Norton IT. Encapsulation systems for the delivery of hydrophilic nutraceuticals. Published online 2017. Accessed September 24, 2023. https://core.ac.uk/download/pdf/ 267298372.pdf
12. Thalkari AvinashB, Karwa PawanN, Thorat VivekM, Jadhav SakshiK. Overview of neutraceuticals. Res J Pharmacol Pharmacodyn. 2020; 12(3): 130. doi:10.5958/2321-5836.2020.00023.3
13. Wang L, Huang X, Jing H, Ma C, Wang H. Bilosomes as effective delivery systems to improve the gastrointestinal stability and bioavailability of epigallocatechin gallate (EGCG). Food Res Int. 2021; 149: 110631.
14. Ahn JH, Kim YP, Kim HS. Effect of natural antioxidants on the lipid oxidation of microencapsulated seed oil. Food Control. 2012; 23: 528-554. doi:10.1016/j.foodcont.2011.08.026
15. Smith AP, Sutherland D, Hewlett P. An investigation of the acute effects of oligofructose-enriched inulin on subjective wellbeing, mood and cognitive performance. Nutrients. 2015; 7(11): 8887-8896. doi:10.3390/nu7115441
16. Anilkumar K, Anitha KI. 18 Clinical Research—History of Regulations. Clin Asp Funct Foods Nutraceuticals. Published online 2014: 257.
17. Jadhav CA, Vikhe DN, Jadhav RS. Global and domestic market of herbal medicines: A review. Res J Sci Technol. 2020; 12(4): 327-330. doi:10.5958/2349-2988.2020.00049.2
18. Kattyar SL, Patil PS, Patil SV, Kadam SS. Phytosomes and Recent research on Phytosomal Drugs. Asian J Pharm Anal. Published online March 5, 2022: 61-69. doi:10.52711/2231-5675.2022.00012
19. Kulkarni RR, Phadtare DG, Saudagar RB. A Novel Approach Towards Nanosuspension. Asian J Pharm Res. 2015; 5(4): 186. doi:10.5958/2231-5691.2015.00029.5
20. Gonzalez Y, Ian T. Encapsulation systems for the delivery of hydrophilic nutraceuticals: Food application. Biotechnol Adv. Published online 2017.
21. Waglewska E, Pucek-Kaczmarek A, Bazylińska U. Novel surface-modified bilosomes as functional and biocompatible nanocarriers of hybrid compounds. Nanomaterials. 2020; 10(12): 2472.
22. Aslam S, Ahmad M, Riaz M. Stability of Carotenoids. In: Zia-Ul-Haq M, Dewanjee S, Riaz M, eds. Carotenoids: Structure and Function in the Human Body. Springer International Publishing; 2021: 251-315. doi:10.1007/978-3-030-46459-2_8
23. Durazzo A, Nazhand A, Lucarini M, et al. An updated overview on nanonutraceuticals: Focus on nanoprebiotics and nanoprobiotics. Int J Mol Sci. 2020; 21(7): 2285.
24. Bhairav BA, Bachhav JK, Saudagar RB. Review on Solubility Enhancement Techniques. Asian J Pharm Res. 2016; 6(3): 175. doi:10.5958/2231-5691.2016.00025.3
25. Srinivasan K, Kumaravel S. Unraveling the potential phytochemical compounds of Gymnema sylvestre through GC-MS study. Int J Pharm Pharm Sci. 2016; 8(1): 1-4.
26. Alonso-Estrada D, Ochoa-Viñals N, Pacios-Michelena S, et al. No Solid Colloidal Carriers: Aspects Thermodynamic the Immobilization Chitinase and Laminarinase in Liposome. Front Bioeng Biotechnol. 2022; 9: 793340.
27. Ashaolu TJ. Emerging applications of nanotechnologies to probiotics and prebiotics. Int J Food Sci Technol. 2021; 56(8): 3719-3725. doi:10.1111/ijfs.15020
28. Gidde ND, Raut ID, Nitalikar MM, Mohite SK, Magdum CS. Pharmacosomes as Drug Delivery System: An Overview. Asian J Pharm Res. Published online May 11, 2021: 122-127. doi:10.52711/2231-5691.2021.00023
29. Shukla A, Mishra V, Kesharwani P. Bilosomes in the context of oral immunization: development, challenges and opportunities. Drug Discov Today. 2016; 21(6): 888-899.
30. Rajput T, Chauhan MK. Bilosome: a bile salt based novel carrier system gaining interest in pharmaceutical research. J Drug Deliv Ther. 2017; 7(5): 4-16.
31. Mali AD, Bathe RS. An Updated Review on Microballoon for Better Approach in Gastro Retention. Asian J Res Pharm Sci. 2015; 5(3): 188. doi:10.5958/2231-5659.2015.00028.4
32. Ahmad J, Singhal M, Amin S, et al. Bile salt stabilized vesicles (bilosomes): a novel nano-pharmaceutical design for oral delivery of proteins and peptides. Curr Pharm Des. 2017; 23(11): 1575-1588.
33. Abdel-moneum R, Abdel-Rashid RS. Bile salt stabilized nanovesicles as a promising drug delivery technology: A general overview and future perspectives. J Drug Deliv Sci Technol. Published online 2022: 104057.
34. Palekar-Shanbhag P, Lande S, Chandra R, Rane D. Bilosomes: superior vesicular carriers. Curr Drug Ther. 2020; 15(4): 312-320.
35. Subramani T, Ganapathyswamy H. An overview of liposomal nano-encapsulation techniques and its applications in food and nutraceutical. J Food Sci Technol. 2020; 57(10): 3545-3555. doi:10.1007/s13197-020-04360-2
36. Reque PM, Brandelli A. Encapsulation of probiotics and nutraceuticals: Applications in functional food industry. Trends Food Sci Technol. 2021; 114: 1-10.
37. Nooshkam M, Varidi M. Maillard conjugate-based delivery systems for the encapsulation, protection, and controlled release of nutraceuticals and food bioactive ingredients: A review. Food Hydrocoll. 2020; 100: 105389.
38. Kailasapathy K. Encapsulation technologies for functional foods and nutraceutical product development. CABI Rev. 2009; 2009: 1-19. doi:10.1079/PAVSNNR20094033
39. Garti N, McClements DJ. Encapsulation Technologies and Delivery Systems for Food Ingredients and Nutraceuticals. Elsevier; 2012. Accessed September 26, 2023. https://books.google.com/books?hl=en&lr=&id=qHNHAgAAQBAJ&oi=fnd&pg=PP1&dq=encapsulation+methods+for+nutraceuticals&ots=w8iemFAi3K&sig=gpsay9z-6CN-H7NN5b0ZWpBnvRo
40. Akbari-Alavijeh S, Shaddel R, Jafari SM. Encapsulation of food bioactives and nutraceuticals by various chitosan-based nanocarriers. Food Hydrocoll. 2020; 105: 105774.
41. Ibrahim TM. Exploitation of transdermal nanobilosomal gel platforms for ameliorating anti-diabetic activity of empagliflozin following I-optimal design. J Drug Deliv Sci Technol. 2023; 84: 104455.
42. Elnaggar YS, Omran S, Hazzah HA, Abdallah OY. Anionic versus cationic bilosomes as oral nanocarriers for enhanced delivery of the hydrophilic drug risedronate. Int J Pharm. 2019; 564: 410-425.
43. Elnaggar Y. Multifaceted applications of bile salts in pharmacy: an emphasis on nanomedicine. Int J Nanomedicine. Published online June 2015: 3955. doi:10.2147/IJN.S82558
44. Elkomy MH, Eid HM, Elmowafy M, et al. Bilosomes as a promising nanoplatform for oral delivery of an alkaloid nutraceutical: improved pharmacokinetic profile and snowballed hypoglycemic effect in diabetic rats. Drug Deliv. 2022; 29(1): 2694-2704. doi:10.1080/10717544.2022.2110997
45. Abbas H, El-Feky YA, Al-Sawahli MM, EL-Deeb NM, El-Nassan HB, Zewail M. Development and optimization of curcumin analog nano-bilosomes using 2 1 .3 1 full factorial design for anti-tumor profiles improvement in human hepatocellular carcinoma: in-vitro evaluation, in-vivo safety assay. Drug Deliv. 2022; 29(1): 714-727. doi:10.1080/10717544.2022.2044938
46. Aziz DE, Abdelbary AA, Elassasy AI. Investigating superiority of novel bilosomes over niosomes in the transdermal delivery of diacerein: in vitro characterization, ex vivo permeation and in vivo skin deposition study. J Liposome Res., 2019; 29(1): 73-85. doi:10.1080/08982104.2018.1430831
47. Mohsen AM, Salama A, Kassem AA. Development of acetazolamide loaded bilosomes for improved ocular delivery: Preparation, characterization and in vivo evaluation. J Drug Deliv Sci Technol. 2020; 59: 101910.
48. Markad MH, Mankar SD. Review on: Solubility Enhancement of Poorly Water Soluble Drugs. Asian J Res Pharm Sci. Published online August 10, 2022: 231-238. doi:10.52711/2231-5659.2022.00041
49. Albash R, El-Nabarawi MA, Refai H, Abdelbary AA. Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment. Int J Nanomedicine. 2019; Volume 14: 6555-6574. doi:10.2147/IJN.S213613
50. Kommuru TR, Gurley BJ, Khan MA, Reddy IK, Indra K. Reddy. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm. 2001; 212(2): 233-246. doi:10.1016/s0378-5173(00)00614-1
51. Baker A. Hepatosplenomegaly. Paediatr Child Health. 2017; 27(5): 247-249. doi:10.1016/j.paed.2017.02.005
52. Debnath S, Kumar THH. An Overview on Pharmacokinetics and Pharmacokinetic Modeling. Asian J Res Pharm Sci. 2020; 10(2): 124. doi:10.5958/2231-5659.2020.00023.5
53. Abdelbary G, Amin M, Salah S. Self nano-emulsifying simvastatin based tablets: design and in vitro/in vivo evaluation. Pharm Dev Technol. 2012;18. doi:10.3109/10837450.2012.672989
54. Elkomy MH, Alruwaili NK, Elmowafy M, et al. Surface-modified bilosomes nanogel bearing a natural plant alkaloid for safe management of rheumatoid arthritis inflammation. Pharmaceutics. 2022; 14(3): 563.
55. Ahmed S, Kassem MA, Sayed S. Bilosomes as Promising Nanovesicular Carriers for Improved Transdermal Delivery: Construction, in vitro Optimization, ex vivo Permeation and in vivo Evaluation. Int J Nanomedicine. 2020; Volume 15: 9783-9798. doi:10.2147/IJN.S278688
56. Nemr AA, El-Mahrouk GM, Badie HA. Hyaluronic acid-enriched bilosomes: an approach to enhance ocular delivery of agomelatine via D-optimal design: formulation, in vitro characterization, and in vivo pharmacodynamic evaluation in rabbits. Drug Deliv. 2022; 29(1): 2343-2356. doi:10.1080/10717544.2022.2100513
57. Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery. Drug Dev Ind Pharm. 2010; 36(11): 1330-1339. doi:10.3109/03639041003801885
58. Bouwman Y, Andersen LM. GMP and preparation in hospital pharmacies. Eur J Hosp Pharm Sci Pract. 2012; 19(5): 469-473.
59. Shaikh S, Bhagwat G. Colloidal Drug Delivery of Simvastatin for Prolonged Drug Release and Increased Bioavailability. Asian J Res Pharm Sci. Published online May 22, 2023; 130-138. doi:10.52711/2231-5659.2023.00024
60. Jain KK. Personalized medicine. Curr Opin Mol Ther. 2002; 4(6): 548-558.
61. Conacher M, Alexander J, Brewer JM. Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes). Vaccine. 2001; 19(20-22): 2965-2974.
62. Ayogu IJ, Ogbonna O, Ayolugbe CI, Attama AA. Evaluation of the pharmacodynamic activity of insulin from bilosomal formulation. Curr Drug Deliv., 2009; 6(4): 415-418.
63. Mura S, Couvreur P. Nanotheranostics for personalized medicine. Adv Drug Deliv Rev., 2012; 64(13): 1394-1416. doi:10.1016/ j.addr.2012.06.006
64. Hamburg MA, Collins FS. The Path to Personalized Medicine. N Engl J Med. 2010; 363(4): 301-304. doi:10.1056/NEJMp1006304
65. Chan IS, Ginsburg GS. Personalized medicine: progress and promise. Annu Rev Genomics Hum Genet. 2011; 12: 217-244. doi:10.1146/annurev-genom-082410-101446